These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27363205)

  • 1. [Site-specific PEGylation of recombinant lysostaphin].
    Lu H; Zhangi Y; Huang Q
    Sheng Wu Gong Cheng Xue Bao; 2016 Jan; 32(1):127-34. PubMed ID: 27363205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Site-directed mutagenesis and sulfhydryl PEGylation of lysostaphin].
    Wu H; Fang W; Yuan J; Peng H; Zhang X; Wang Y; Xiao Y
    Sheng Wu Gong Cheng Xue Bao; 2011 Nov; 27(11):1623-30. PubMed ID: 22393717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol.
    Walsh S; Shah A; Mond J
    Antimicrob Agents Chemother; 2003 Feb; 47(2):554-8. PubMed ID: 12543658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Bioconjugation Strategy Using Elevated Hydrostatic Pressure: A Case Study for the Site-Specific Attachment of Polyethylene Glycol (PEGylation) of Recombinant Human Ciliary Neurotrophic Factor.
    Wang Q; Zhang C; Guo F; Li Z; Liu Y; Su Z
    Bioconjug Chem; 2017 Nov; 28(11):2841-2848. PubMed ID: 29053917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific PEGylation of bone morphogenetic protein-2 cysteine analogues.
    Hu J; Duppatla V; Harth S; Schmitz W; Sebald W
    Bioconjug Chem; 2010 Oct; 21(10):1762-72. PubMed ID: 20886828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of the antibacterial peptidase lysostaphin from Staphylococcus simulans: Adverse influence of Zn
    Chandra Ojha S; Imtong C; Meetum K; Sakdee S; Katzenmeier G; Angsuthanasombat C
    Protein Expr Purif; 2018 Nov; 151():106-112. PubMed ID: 29944958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering active lysostaphin variants that incorporate noncanonical amino acids and characterizing the effects of site-specific PEGylation.
    Batugal T; Pendyala G; Tomasovic L; Varner C; Caplin JD; Page AM; Davis M; Satola SW; García AJ; Kane RS
    Biotechnol Bioeng; 2023 Jun; 120(6):1694-1701. PubMed ID: 36810983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantitative specific detection of Staphylococcus aureus based on recombinant lysostaphin and ATP bioluminescence].
    Li Y; Mi Z; An X; Zhou Y; Tong Y
    Sheng Wu Gong Cheng Xue Bao; 2014 Aug; 30(8):1283-90. PubMed ID: 25423758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of site-specific ScFv PEGylation for tumor-targeting pharmaceuticals.
    Natarajan A; Xiong CY; Albrecht H; DeNardo GL; DeNardo SJ
    Bioconjug Chem; 2005; 16(1):113-21. PubMed ID: 15656582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification, and C-terminal site-specific PEGylation of cysteine-mutated glucagon-like peptide-1.
    Gao M; Tian H; Ma C; Gao X; Guo W; Yao W
    Appl Biochem Biotechnol; 2010 Sep; 162(1):155-65. PubMed ID: 19728172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-phase N-terminus PEGylation of recombinant human fibroblast growth factor 2 on heparin-sepharose column.
    Huang Z; Ye C; Liu Z; Wang X; Chen H; Liu Y; Tang L; Zhao H; Wang J; Feng W; Li X
    Bioconjug Chem; 2012 Apr; 23(4):740-50. PubMed ID: 22433083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen/deuterium exchange mass spectrometry and site-directed disulfide cross-linking suggest an important dynamic interface between the two lysostaphin domains.
    Lu HR; Gu MG; Huang Q; Huang JJ; Lu WY; Lu H; Huang QS
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1872-81. PubMed ID: 23380729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical and pharmacokinetic characterization of highly potent recombinant L-methionine gamma-lyase conjugated with polyethylene glycol as an antitumor agent.
    Takakura T; Takimoto A; Notsu Y; Yoshida H; Ito T; Nagatome H; Ohno M; Kobayashi Y; Yoshioka T; Inagaki K; Yagi S; Hoffman RM; Esaki N
    Cancer Res; 2006 Mar; 66(5):2807-14. PubMed ID: 16510603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation and characterization of mono PEGylated recombinant human interferon omega].
    Liu H; Cheng YG; Pan HC; Xu B; Peng L; Yang HT; Guo W
    Yao Xue Xue Bao; 2012 Mar; 47(3):393-8. PubMed ID: 22645765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus.
    Gründling A; Schneewind O
    J Bacteriol; 2006 Apr; 188(7):2463-72. PubMed ID: 16547033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine-specific PEGylation of rhG-CSF via selenylsulfide bond.
    Kunstelj M; Fidler K; Skrajnar S; Kenig M; Smilović V; Kusterle M; Caserman S; Zore I; Porekar VG; Jevševar S
    Bioconjug Chem; 2013 Jun; 24(6):889-96. PubMed ID: 23600957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New effective sources of the Staphylococcus simulans lysostaphin.
    Szweda P; Kotłowski R; Kur J
    J Biotechnol; 2005 May; 117(2):203-13. PubMed ID: 15823409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
    Bell SJ; Fam CM; Chlipala EA; Carlson SJ; Lee JI; Rosendahl MS; Doherty DH; Cox GN
    Bioconjug Chem; 2008 Jan; 19(1):299-305. PubMed ID: 18020402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, modeling, and expression of erythropoietin cysteine analogs in Pichia pastoris: improvement of mean residence times and in vivo activities through cysteine-specific PEGylation.
    Maleki A; Madadkar-Sobhani A; Roohvand F; Najafabadi AR; Shafiee A; Khanahmad H; Cohan RA; Namvar N; Tajerzadeh H
    Eur J Pharm Biopharm; 2012 Apr; 80(3):499-507. PubMed ID: 22068050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.